Trial Profile
A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 09 Nov 2023
Price :
$35
*
At a glance
- Drugs BLI 801 (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Braintree Laboratories
- 25 Jul 2017 Status changed from active, no longer recruiting to completed.
- 13 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Jul 2016 New trial record